Skip to main content

Healthcare & Biotech

Senior Helpers Greenville Becomes First US Home Care Firm CHAP-Certified

Image
Senior Helpers Greenville Becomes First US Home Care Firm CHAP-Certified

Greenville, S.C. – September 17, 2026 -- Senior Helpers Greenville has become the first private duty in-home care provider in the United States to earn Age-Friendly Care at Home certification from the Community Health Accreditation Partners (CHAP), the locally owned franchise confirmed August 27, 2026.

CHAP certification validates a 4Ms clinical framework across daily operations

The certification requires providers to embed the 4Ms Framework -- What Matters, Medication, Mentation, and Mobility -- into every client interaction, a research-backed model designed to reduce hospitalization risk and improve outcomes for aging-in-place seniors. Teresa Harbour, COO of CHAP, credited the location's prior deployment of clinical tools, including its LIFE Profile hospitalization-risk assessment and Senior Gems dementia care program, as groundwork that made the certification a natural extension of existing practice.

Spa Medicca Adds Dr. Sherock & Associates to Ohio Women's Health Network

Image
Spa Medicca Adds Dr. Sherock & Associates to Ohio Women's Health Network

Canton, Ohio – September 17, 2026 -- Spa Medicca has finalized a partnership with Dr. Sherock & Associates, a women's health practice serving Massillon and Orrville, Ohio, marking the medical aesthetics and wellness platform's latest acquisition in the state.

Seven Hills Capital financed the transaction as Spa Medicca's private equity partner

Seven Hills Capital, an operator-centric healthcare private equity firm, served as Spa Medicca's financial partner in completing the deal and will continue backing the organization's regional expansion strategy.

ABMS Names Record 23 Scholars for AI, Burnout Research in 2026-27

Image
ABMS Names Record 23 Scholars for AI, Burnout Research in 2026-27

Chicago – September 17, 2026 -- The American Board of Medical Specialties (ABMS) has selected a record 23 physicians for its 2026-2027 Scholars Program, each receiving a $15,000 financial award to conduct research on board certification, artificial intelligence in clinical assessment, and physician burnout.

ABMS expands its scholar cohort to a record size since the program's 2014 launch

The one-year, part-time initiative supports early-career physicians and researchers focused on initial and continuing board certification. Recipients remain at their home institutions, work with self-selected mentors, and join monthly virtual sessions with peers, mentors, Member Board leaders and program alumni. Greg Ogrinc, MD, ABMS Senior Vice President for Certification Standards and Programs, said the rising volume of applicants reflects growing interest in research addressing certification and physician assessment.

PRC-Saltillo Launches Genesis AAC Devices, Shipping in October

Image
PRC-Saltillo Launches Genesis AAC Devices, Shipping in October

Wooster, Ohio – September 17, 2026 -- PRC-Saltillo has launched its Genesis product line globally, introducing two Windows-based augmentative and alternative communication (AAC) devices for individuals with acquired or long-term complex communication needs, including ALS and cerebral palsy.

Genesis debuts in two screen sizes with expanded access options

The line launches with the 13-inch Genesis 13 and 16-inch Genesis 16, both built on 60 years of engineering, clinical, linguistic, and communicator expertise, according to the company. The devices feature vibrant displays, a three-inch angled partner display, customizable quick-access controls, front- and rear-facing surround audio, a multi-angle kickstand, larger power and volume buttons, extended battery life, and increased storage capacity.

RBS to Vet New Partners for Anoma Cancer Collective at ASTRO 2026

Nashville – September 17, 2026 -- Radiation Business Solutions (RBS) will meet with prospective partner organizations at the American Society for Radiation Oncology (ASTRO) Annual Meeting as part of a limited expansion phase for the Anoma Cancer Collective (ACC), a nonprofit foundation supporting community cancer care.

ACC currently backs cancer centers across five states

ACC supports community cancer programs in Alabama, Texas, Florida, Georgia and Oklahoma, and is evaluating a select number of additional markets for expansion. The organization operates as a nonprofit foundation financed through the bond market rather than through traditional acquisition capital.

Nutramax Doubles Veterinary CE Conference After 2,000+ Sign-Ups

Lancaster, S.C. – September 17, 2026 -- Nutramax Laboratories is splitting its flagship veterinary continuing education event into two annual conferences after registration for its 2026 gathering topped 2,000 attendees, a record for the program.

Nutramax expands A Different Way to CETM to fall and spring events

The company will hold a fall conference at the Gaylord Opryland Resort and Convention Center in Nashville, Tennessee, from Oct. 17-20, 2027, followed by a spring conference at the Gaylord Palms Resort and Convention Center in Orlando, Florida, from April 23-26, 2028. Both events will offer veterinary professionals up to 20 CE credits across more than 100 sessions, with meals included and a dedicated kids' zone for attending families.

Outcomes4Me Hires OpenEvidence Veteran Jim Longley as Chief Revenue Officer

Boston – September 17, 2026 -- Outcomes4Me Inc. has appointed Jim Longley, formerly Senior Vice President of AI Partnerships at OpenEvidence, as its new Chief Revenue Officer to lead commercial expansion across pharma, provider, and diagnostic partnerships.

Longley brings two decades of health tech revenue scaling to the role

Before OpenEvidence, Longley spent nearly five years at GoodRx, rising to Senior Vice President and Head of Commercial, and prior to that spent over six years at Doximity as Vice President for Business Development and Product Innovation. Outcomes4Me CEO Maya R. Said, Sc.D., said Longley has a track record of scaling health tech companies to hundreds of millions of dollars in revenue.

Davion Healthcare's £30M Bond Debuts on Vienna MTF for M&A

Dublin – September 16, 2026 -- Davion Healthcare Plc has secured admission of a £30 million senior secured bond to trading on the Vienna MTF, operated by Wiener Börse AG, giving the Irish healthcare group a dedicated capital pool to fund acquisitions.

Bond carries 10.5% fixed coupon over five-year term

The bond, issued through financing subsidiary Davion Healthcare Finance Ltd, commenced in August 2026 and carries a fixed annual coupon of 10.5%. It trades under ISIN GB00BTH2SB89, with a denomination of £100,000 per unit.

Proceeds target acquisitions across five healthcare segments

Davion plans to deploy the capital toward acquiring established, cash-generative businesses in medical devices, diagnostics, medical distribution, healthcare technology and healthcare services. Proceeds are released on an acquisition-by-acquisition basis through Davion Healthcare Finance Ltd, with security granted over each acquired asset.

Intuitive Wins CE Mark for da Vinci SP Vaginal Surgery Use

Image
Intuitive Wins CE Mark for da Vinci SP Vaginal Surgery Use

Aubonne – September 16, 2026 -- Intuitive has secured CE mark approval for its da Vinci SP surgical system to perform transvaginal gynecologic procedures, marking the first such indication for the Single Port platform anywhere in the world.

Approval widens da Vinci SP's European surgical scope beyond five existing categories

The new indication adds to da Vinci SP's current CE-marked applications in Europe, which cover endoscopic abdominopelvic, thoracoscopic, transoral otolaryngology, transanal colorectal, and breast procedures. The system now supports natural orifice surgery across transoral, transanal, and transvaginal routes.

IASLC Waives Membership Fees for Clinicians in Low-Income Nations

Denver – September 16, 2026 -- The International Association for the Study of Lung Cancer (IASLC) has launched a Complimentary IASLC Full Membership program for healthcare professionals in World Bank-designated low-income and lower-middle-income economies, eliminating financial barriers to its global thoracic oncology network.

Board approves fee waiver to widen access to research and clinical resources

The IASLC Board of Directors approved the initiative this spring, extending full membership benefits at no cost to clinicians, researchers, nurses, allied health professionals and patient advocates in eligible countries. Eligibility is determined annually using World Bank country income classifications.